Similar articles

• Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).

  Robinson E, Haim N, Segal R, Veseley Z, Mekori T. Robinson E, et al. Cancer Treat Rep. 1985 Mar;69(3):251-8. Cancer Treat Rep. 1985. PMID: 2983892
• Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung.

  Herman TS, Jones SE, McMahon LJ, Lloyd RE, Heusinkveld RS, Miller RC, Salmon SE. Herman TS, et al. Cancer Treat Rep. 1977 Aug;61(5):875-9. Cancer Treat Rep. 1977. PMID: 196753 Clinical Trial. No abstract available.
• Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.

  Mintz U, Bitran JD, Cooksey JA, Desser RK, DeMeester TR, Golomb HM. Mintz U, et al. Cancer Treat Rep. 1978 Apr;62(4):567-9. Cancer Treat Rep. 1978. PMID: 77725 Clinical Trial. No abstract available.
• The current management of malignancy. IV.-Cancer of the lung.

  Panettiere FJ. Panettiere FJ. Alaska Med. 1975 May;17(3):35-41. Alaska Med. 1975. PMID: 237422 Review. No abstract available.
• The role of chemotherapy in the treatment of lung cancer.

  Selawry OS. Selawry OS. Semin Oncol. 1974 Sep;1(3):259-72. Semin Oncol. 1974. PMID: 4143488 Review. No abstract available.